Delivery Order SPE2DR25D3504-SPE2DR26F7FG2
Award Date 4/17/26
Potential Completion Date 4/20/26
Potential Value $5.3K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency issued a $14,686.66 delivery order to Amerisourcebergen Drug Corp on April 14, 2026, for drospirenone 4 mg tablets (28-count). The order is issued under the DLA Troop Support Medical Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 through December 2026, a comprehensive global pharmaceutical support vehicle enabling supply of pharmaceutical products and medical supplies to military healthcare programs worldwide. Place of performance is Conshohocken,...
- <p>The Defense Logistics Agency issued a $3,988.52 delivery order to Amerisourcebergen Drug Corp on February 9, 2026, for drospirenone-EE 3–0.02 mg tablets (28 count).</p> <p>Place of performance is Conshohocken, PA. The order has a firm fixed price and an ultimate completion date of February 10, 2026. No set-aside was used.</p>
- <p>The Defense Logistics Agency issued a delivery order to Amerisourcebergen Drug Corp on March 17, 2026, for Drospirenone-EE 3-0.02 mg tablets with a ceiling value of $1,779.84.</p> <p>Place of performance is Conshohocken, PA. The order is firm fixed price with an ultimate completion date of March 18, 2026. No set-aside was used.</p>
- <p>The Defense Logistics Agency issued a delivery order to Amerisourcebergen Drug Corp on February 26, 2026, for Drospirenone 4mg tablets with a ceiling value of $17,115.81.</p> <p>Place of performance is Conshohocken, PA. Ultimate completion date is February 27, 2026. The order was priced firm fixed price and carried no set-aside.</p>
- The Defense Logistics Agency awarded a $2,816.89 delivery order to AmerisourceBergen Drug Corp for Drospirenone-EE 3-0.02 mg tablets (28-count packaging) on August 21, 2025, with completion scheduled for August 22, 2025. This contract represents a firm fixed-price, competitively awarded delivery order with no set-aside designation. The award was fulfilled by AmerisourceBergen Drug Corp's Corporate Office division, headquartered in Conshohocken, Pennsylvania, which serves as a major...
- The Defense Logistics Agency awarded a delivery order valued at $8,531.36 to AmerisourceBergen Drug Corp for Drospirenone-EE 3-0.02 mg tablets (28-count packages) on November 5, 2025, with completion targeted for November 6, 2025. This is a firm fixed-price delivery order with no set-aside designation, performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a pediatric contraceptive pharmaceutical product procured through competitive delivery order procedures...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on September 24, 2025, for the supply of drospirenone-ethinyl estradiol 3-0.02 mg tablets in quantities of 28 units. The contract is a firm fixed-price delivery order with a ceiling value of $1,963.51, with an ultimate completion date of September 25, 2025. This award was not designated as a set-aside and was competitively awarded. The place of performance is located in Conshohocken, Pennsylvania,...
- The Defense Logistics Agency awarded a delivery order valued at $1,657.53 to AmerisourceBergen Drug Corp for the supply of Drospirenone-EE 3-0.02 mg tablets (28-count packaging) on January 28, 2026, with completion scheduled for January 29, 2026. This is a firm fixed-price delivery order issued without set-aside designation, indicating open and competitive procurement. The point of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters....
- The Defense Logistics Agency awarded a delivery order valued at $2,117.45 to AmerisourceBergen Drug Corp for the supply of Drospirenone-EE 3-0.02 mg tablets (28-count units) on January 27, 2026, with completion expected by January 28, 2026. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a task order under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 3, 2025, for the supply of Drospirenone-EE 3-0.02 mg tablets in quantities of 28 units. This competitively awarded, non-set-aside contract carries a ceiling value of $1,397.64 and employs firm fixed pricing, with an ultimate completion date of November 4, 2025. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This...
- SPE2DR25D3504Indefinite Delivery Contract
- SPE2DR25D3504-SPE2DR26F7FG2Delivery Order
The Defense Logistics Agency issued a $5,318.77 delivery order to AmerisourceBergen Drug Corp on April 17, 2026, for drospirenone-ethinyl estradiol 3-0.02 mg tablets (28-count). Place of performance is Conshohocken, PA. Ultimate completion date is April 20, 2026. The order is firm fixed price with no set-aside applied. The parent vehicle is the DLA Troop Support Medical indefinite delivery contract under which AmerisourceBergen supplies brand-name and generic pharmaceuticals, specialty injectables, vaccines, and medical devices to Defense Health Agency and subordinate military medical facilities worldwide.
Generated 7/16/26, 10:11 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.3k | 4/16/26 |